FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.” Journal of Clinical Investigation

TitleFGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.” Journal of Clinical Investigation
Publication TypeJournal Article
Year of Publication2021
AuthorsReilly SM, Abu-Odeh M, Ameka M, Deluca JH, Naber MC, Dadpey B, Ebadat N, Gomez AV, Peng X, Poirier BA, Walk E, Potthoff MJ, Saltiel AR
JournalThe Journal of Clinical Investigation
URLhttps://www.jci.org/articles/view/145546